Functional Mechanism of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Animal Models with Alzheimer's Disease: Inhibition of Neuroinflammation
- PMID: 34566422
- PMCID: PMC8456430
- DOI: 10.2147/JIR.S327538
Functional Mechanism of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Animal Models with Alzheimer's Disease: Inhibition of Neuroinflammation
Abstract
The transplantation of bone marrow-derived mesenchymal stem cells (BMMSCs) alleviates neuropathology and improves cognitive deficits in animal models with Alzheimer's disease. However, the underlying mechanisms remain to be determined. Available data demonstrate transplanted BMMSCs can inhibit neuroinflammation, which may be related to microglial M1/M2 polarization and is regulated by the secretion of autocrine and paracrine cytokines. BMMSCs also mitigate Aβ plaques and Tau tangles in the brain, which may be associated with the recruitment of peripheral blood monocytes and the subsequent comprehensive effects. The therapeutic effects of stem cells involve potential mechanisms such as immunomodulation, apoptosis, and proliferation. BMMSC-mediated functional reconstruction through dynamic remodeling develops a novel balance. Herein, present review recapitulates the molecular basis of BMMSC-assisted biological processes and summarizes the possible mechanisms related to the interaction between BMMSCs and microglia. The transplanted BMMSCs can suppress neuroinflammation that plays a key role in the pathogenesis of Alzheimer's disease.
Keywords: Alzheimer’s disease; apoptosis; bone marrow-derived mesenchymal stem cells; immunomodulation; microglia.
© 2021 Qin et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures





Similar articles
-
Transplantation of bone marrow mesenchymal stem cells improves cognitive deficits and alleviates neuropathology in animal models of Alzheimer's disease: a meta-analytic review on potential mechanisms.Transl Neurodegener. 2020 May 27;9(1):20. doi: 10.1186/s40035-020-00199-x. Transl Neurodegener. 2020. PMID: 32460886 Free PMC article.
-
The functional mechanism of bone marrow-derived mesenchymal stem cells in the treatment of animal models with Alzheimer's disease: crosstalk between autophagy and apoptosis.Stem Cell Res Ther. 2022 Mar 3;13(1):90. doi: 10.1186/s13287-022-02765-8. Stem Cell Res Ther. 2022. PMID: 35241159 Free PMC article. Review.
-
Novel Balance Mechanism Participates in Stem Cell Therapy to Alleviate Neuropathology and Cognitive Impairment in Animal Models with Alzheimer's Disease.Cells. 2021 Oct 15;10(10):2757. doi: 10.3390/cells10102757. Cells. 2021. PMID: 34685737 Free PMC article. Review.
-
Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice.Stem Cell Res Ther. 2015 May 27;6(1):104. doi: 10.1186/s13287-015-0091-4. Stem Cell Res Ther. 2015. PMID: 26012584 Free PMC article.
-
Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.Int J Mol Sci. 2020 Jun 25;21(12):4532. doi: 10.3390/ijms21124532. Int J Mol Sci. 2020. PMID: 32630597 Free PMC article.
Cited by
-
Bone Marrow-Derived Mesenchymal Stem Cells and γ-Secretase Inhibitor Treatments Suppress Amyloid-β25-35-Induced Cognitive Impairment in Rat Dams and Cortical Degeneration in Offspring.Stem Cells Int. 2023 May 25;2023:2690949. doi: 10.1155/2023/2690949. eCollection 2023. Stem Cells Int. 2023. PMID: 37274020 Free PMC article.
-
Alzheimer's Disease: From Pathogenesis to Mesenchymal Stem Cell Therapy - Bridging the Missing Link.Front Cell Neurosci. 2022 Feb 7;15:811852. doi: 10.3389/fncel.2021.811852. eCollection 2021. Front Cell Neurosci. 2022. PMID: 35197824 Free PMC article. Review.
-
Exploration of Cytokines That Impact the Therapeutic Efficacy of Mesenchymal Stem Cells in Alzheimer's Disease.Bioengineering (Basel). 2025 Jun 12;12(6):646. doi: 10.3390/bioengineering12060646. Bioengineering (Basel). 2025. PMID: 40564462 Free PMC article.
-
Astrocytic MicroRNAs and Transcription Factors in Alzheimer's Disease and Therapeutic Interventions.Cells. 2022 Dec 17;11(24):4111. doi: 10.3390/cells11244111. Cells. 2022. PMID: 36552875 Free PMC article. Review.
-
Stem cell therapy for Alzheimer's disease: An overview of experimental models and reality.Animal Model Exp Med. 2022 Feb;5(1):15-26. doi: 10.1002/ame2.12207. Epub 2022 Jan 29. Animal Model Exp Med. 2022. PMID: 35229995 Free PMC article. Review.
References
-
- Tang M, Ryman DC, McDade E, et al. Neurological manifestations of autosomal dominant familial Alzheimer’s disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). Lancet Neurol. 2016;15(13):1317–1325. doi:10.1016/S1474-4422(16)30229-0 - DOI - PMC - PubMed
-
- Fertan E, Rodrigues GJ, Wheeler RV, et al. Cognitive Decline, Cerebral-Spleen Tryptophan Metabolism, Oxidative Stress, Cytokine Production, and Regulation of the Txnip Gene in a Triple Transgenic Mouse Model of Alzheimer Disease. Am J Pathol. 2019;189(7):1435–1450. doi:10.1016/j.ajpath.2019.03.006 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources